G1 Therapeutics Inc. [GTHX] is -7.79% lower this YTD. Is it still time to buy?

G1 Therapeutics Inc. [NASDAQ: GTHX] gained 5.32% on the last trading session, reaching $24.37 price per share at the time. G1 Therapeutics Inc. represents 37.66 million in outstanding shares, while the company has a total market value of $850.27 million with the latest information. GTHX stock price has been found in the range of $22.98 to $24.74.

If compared to the average trading volume of 480.89K shares, GTHX reached a trading volume of 557219 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about G1 Therapeutics Inc. [GTHX]:

H.C. Wainwright have made an estimate for G1 Therapeutics Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 21, 2020. The new note on the price target was released on August 08, 2019, representing the official price target for G1 Therapeutics Inc. stock. Previously, the target price had yet another raise to $55, while B. Riley FBR analysts kept a Buy rating on GTHX stock.

The Average True Range (ATR) for G1 Therapeutics Inc. is set at 1.52 The Price to Book ratio for the last quarter was 4.00, with the Price to Cash per share for the same quarter was set at 6.95.

Trading performance analysis for GTHX stock

G1 Therapeutics Inc. [GTHX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.03. With this latest performance, GTHX shares gained by 35.31% in over the last four-week period, additionally sinking by -21.39% over the last 6 months – not to mention a drop of -15.23% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GTHX stock in for the last two-week period is set at 71.47, with the RSI for the last a single of trading hit 73.09, and the three-weeks RSI is set at 68.44 for G1 Therapeutics Inc. [GTHX]. The present Moving Average for the last 50 days of trading for this stock 17.11, while it was recorded at 23.89 for the last single week of trading, and 20.56 for the last 200 days.

G1 Therapeutics Inc. [GTHX]: A deeper dive into fundamental analysis

Return on Total Capital for GTHX is now -41.32, given the latest momentum, and Return on Invested Capital for the company is -39.25. Return on Equity for this stock declined to -39.86, with Return on Assets sitting at -37.33. When it comes to the capital structure of this company, G1 Therapeutics Inc. [GTHX] has a Total Debt to Total Equity ratio set at 4.00. Additionally, GTHX Total Debt to Total Capital is recorded at 3.84, with Total Debt to Total Assets ending up at 3.59. Long-Term Debt to Equity for the company is recorded at 3.73, with the Long-Term Debt to Total Capital now at 3.59.

Reflecting on the efficiency of the workforce at the company, G1 Therapeutics Inc. [GTHX] managed to generate an average of -$1,177,375 per employee.G1 Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 13.20 and a Current Ratio set at 13.20.

G1 Therapeutics Inc. [GTHX]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, G1 Therapeutics Inc. posted -0.82/share EPS, while the average EPS was predicted by analysts to be reported at -0.72/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -13.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GTHX.

An analysis of insider ownership at G1 Therapeutics Inc. [GTHX]

There are presently around $663 million, or 93.20% of GTHX stock, in the hands of institutional investors. The top three institutional holders of GTHX stocks are: FMR LLC with ownership of 5,646,329, which is approximately 0.161% of the company’s market cap and around 0.20% of the total institutional ownership; WELLINGTON MANAGEMENT GROUP LLP, holding 3,720,369 shares of the stock with an approximate value of $86.09 million in GTHX stocks shares; and BLACKROCK INC., currently with $59.68 million in GTHX stock with ownership of nearly -0.046% of the company’s market capitalization.

55 institutional holders increased their position in G1 Therapeutics Inc. [NASDAQ:GTHX] by around 1,514,754 shares. Additionally, 48 investors decreased positions by around 3,102,789 shares, while 18 investors held positions by with 24,014,143 shares. The mentioned changes placed institutional holdings at 28,631,686 shares, according to the latest SEC report filing. GTHX stock had 22 new institutional investments in for a total of 396,455 shares, while 18 institutional investors sold positions of 837,848 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam